Broker Name: DBS

Date of Report: 2024

Excerpt from DBS report.

• Report Summary:
• Ultragreen is a global leader in indocyanine green (ICG) for fluorescence guided surgery, holding over 60% market share due to regulatory barriers and superior product profile.
• The ICG market is projected to grow at 11.7% annually through 2030, driven by increasing adoption, international expansion, and robust industry fundamentals, supporting strong earnings growth for Ultragreen.

Above is an excerpt from a report by DBS. Clients of DBS can be the first to access the full report from the DBS website: https://www.dbs.com